APA

Santos T. C., Morton T. J., Moritz M., Pfeifer S., Reise K., Marques A. P., Castro A. G., Reis R. L. & van Griensven M. (20130926). Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators. : Tissue engineering. Part A.

Chicago

Santos Tírcia C, Morton Tatjana J, Moritz Martina, Pfeifer Sabine, Reise Kathrin, Marques Alexandra P, Castro António G, Reis Rui L and van Griensven Martijn. 20130926. Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators. : Tissue engineering. Part A.

Harvard

Santos T. C., Morton T. J., Moritz M., Pfeifer S., Reise K., Marques A. P., Castro A. G., Reis R. L. and van Griensven M. (20130926). Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators. : Tissue engineering. Part A.

MLA

Santos Tírcia C, Morton Tatjana J, Moritz Martina, Pfeifer Sabine, Reise Kathrin, Marques Alexandra P, Castro António G, Reis Rui L and van Griensven Martijn. Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators. : Tissue engineering. Part A. 20130926.